Childhood & Adolescent Obesity & Diabetes Part 1
5E005WEB

Release Date September 2004,thru September 2006. Copyright 2004 by OUHSC. All rights reserved. No part of this program may be reproduced in any manner whatsoever without written permission from the publisher, except as indicated in the instructions herein.

OUHSC, College of Medicine, Office of Continuing Medical Education, 800 N.E. 15th Street, Oklahoma City, OK 73104, (888) 682-6348

PROGRAM INTRODUCTION

COURSE NUMBER 5E005WEB

PURPOSE

Childhood & Adolescent Obesity is become a growing epidemic. The purpose of this presentation is to educate any physician who has juvenile or adolescent patient.

EDUCATIONAL OUTLINE

1. The new epidemic of type 2 Diabetes Mellitus in children and adolescents.
2. The epidemiologic overview of:
   a) the epidemic of type 2 diabetes mellitus by gender and race
   b) the changes in obesity prevalence by decade from 1963 to present
3. The risk factors for diabetes and children and adolescents
4. Current treatment options (or lack thereof) for children and adolescents with diabetes mellitus.
5. WHO (World Health Organization) Criteria for Diagnosis of Type 2 Diabetes Mellitus.
6. Studies to Treat or Prevent Pediatric Type 2 Diabetes Mellitus (STOPP-T2D) clinical trial funded by the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health.
   a) Inclusion and Exclusion Criteria for the Treatment Options for type 2 Diabetes in Adolescents and Youth (TODAY) trial
   b) Study Design of TODAY
   c) Primary Aim and Outcomes of TODAY
   d) Major Secondary Aims and Study Design of TODAY
   e) Compare the efficacy of the three different treatment arms of TODAY
   f) Primary Outcome Assessment Mechanism of TODAY
   g) Participant/volunteer benefits for participation in the TODAY clinical trial

EDUCATIONAL OBJECTIVES

At the conclusion of the program the participants will be able to:

1. Define the new epidemic of type 2 Diabetes Mellitus in children and adolescents.
2. Report the overall lifetime risk of getting diabetes mellitus by gender and race.
3. Report the epidemiologic overview and change in obesity by decade from 1963 to present.
4. Identify the risk factors for diabetes and children.
5. Describe the current treatment options or lack of treatment options for children and adolescents with diabetes mellitus.
6. Describe the STOPP-T2D Studies to Treat or Prevent Pediatric Type 2 Diabetes Mellitus clinical trial funded National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health.
7. Explain the WHO (World Health Organization) Criteria for Diagnosis of Type 2 Diabetes Mellitus.

EXPECTED OUTCOMES

The participating physicians will practice better patient care through the understanding of how to diagnosis and treat type 2 diabetes.

This activity did not receive any commercial support for the development of this presentation.

TARGET AUDIENCE

The target audience includes a) family practitioners, b) internists, c) family medicine, and d) pediatricians.

TABLE OF CONTENTS

• Program introduction
• Course introduction
• Presentation
• CME test questions and answer sheet
• CME Course Evaluation

IMPLEMENTATION

The estimated time for completion of this program is 1.25 hours. In order to get the greatest value from this program, we recommend a five-step process.

1. Review the video and PowerPoint presentation (requires Windows Media Player 9.0 or higher, Internet Explorer 5.0 or later, Netscape Navigator 7.0 or later, or Internet Explorer 5.2.2 or later for the Mac).
2. Print a copy of the test and evaluation (PDF format / Word format).
3. Discuss the information covered with your staff or colleagues.
4. Return to your test answer sheet for a final review and review your test answers.
5. Complete and return the CME test answer sheet and course evaluation.

PROGRAM FACULTY

Kenneth C. Copeland is the CMRI Ruth & Paul Jonas Endowed Chair in Endocrinology/Diabetes and also Professor and Chief of the Pediatric Diabetes and Endocrinology Section. He is the Vice Chairman for the OUHSC Department of Pediatrics and the Medical Director for the OUHSC Pediatric Practice Group.

PROGRAM PLANNING COMMITTEE

• Roger Sheldon, MD, Assistant Dean of Continuing Medical Education University of Oklahoma
• Margie Miller, MS, CPP, Director of Continuing Medical Education University of Oklahoma
• Myrna Page, MPH, CHES, Associate Director of Continuing Medical Education University of Oklahoma
• Kenneth Copeland, MD, CMRI Ruth & Paul Jonas Endowed Chair in Endocrinology/Diabetes

DISCLOSURE POLICY

It is the policy of The University of Oklahoma Health Sciences Center College of Medicine to ensure balance, independence, objectivity and scientific rigor in all its educational programs. All faculty participating in these programs are expected to disclose to the program audiences any real or apparent conflict of interest related to the content of their presentation.

SPEAKER DISCLOSURE

The University of Oklahoma College of Medicine Irwin Brown Office of Continuing Medical Education has adopted a policy regarding disclosure affecting continuing medical educational programs. Program faculty are asked to disclose any affiliations or financial interests they may have in any organization that may have an interest in their comments. The following information was received from the faculty:

Kenneth C. Copeland, MD has no significant financial relationships to disclose.

ACKNOWLEDGMENTS

This presentation was videotaped at the Oklahoma Chapter, American Academy of Pediatrics Meeting in Tulsa. Thank you to Reta Crotzer, Executive Director of OKAAP for allowing OU Television services to film this presentation.

ACCREDITATION AND CREDITS

The University of Oklahoma College of Medicine is accredited by the ACCME to provide continuing medical education for physicians. The University of Oklahoma College of Medicine designates this activity for a maximum of 1.25 category 1 credits toward the AMA Physician's Recognition Award. Each physician should claim only those credits that she/he actually spent in the educational activity.

American Academy of Physician Assistants (AAPA) accepts AMA/PRA Category 1 credit from organizations accredited by ACCME.

HOW TO OBTAIN CONTINUING MEDICAL EDUCATION CREDITS

A certificate of completion will be awarded to physicians completing the program (with a score of 70% or higher). In order to receive your continuing medical education credits, the accompanying answer sheet and course evaluation must be filled out completely and mailed along with a check (made payable to OUHSC/CME) for $25.00 to:

The Irwin Brown Office of Continuing Medical Education
P.O. Box 26901 - ROB 202
Oklahoma City, OK 73190

You may view the test, answer sheet, and course evaluation in PDF and Word format. Viewing the documents in PDF format requires you to have the free Adobe Reader installed on your computer. Viewing the documents in Word format requires you to have Microsoft Word or the Word Viewer installed on your computer. If you have questions, please call us at (888) 682-6348, ext. 6.

You will receive a certificate of completion within 7-10 days after receipt of your test and evaluation. In the event you fail, you will be notified regarding a retake examination on the same concepts.

You may fax your test and course evaluation form to us at (405) 271-3087.